Trade Asensus Surgical, Inc. - ASXC CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.0116 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026207% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003985% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Asensus Surgical Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Prev. Close* | 0.2647 |
Open* | 0.2912 |
1-Year Change* | -28.29% |
Day's Range* | 0.2692 - 0.2912 |
52 wk Range | 0.20-1.18 |
Average Volume (10 days) | 2.02M |
Average Volume (3 months) | 50.29M |
Market Cap | 62.11M |
P/E Ratio | -100.00K |
Shares Outstanding | 264.32M |
Revenue | 5.61M |
EPS | -0.33 |
Dividend (Yield %) | N/A |
Beta | 1.48 |
Next Earnings Date | Feb 29, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Nov 27, 2023 | 0.2647 | 0.0099 | 3.89% | 0.2548 | 0.2774 | 0.2494 |
Nov 24, 2023 | 0.2582 | 0.0236 | 10.06% | 0.2346 | 0.2639 | 0.2283 |
Nov 22, 2023 | 0.2345 | 0.0012 | 0.51% | 0.2333 | 0.2418 | 0.2297 |
Nov 21, 2023 | 0.2315 | 0.0053 | 2.34% | 0.2262 | 0.2433 | 0.2212 |
Nov 20, 2023 | 0.2261 | -0.0022 | -0.96% | 0.2283 | 0.2295 | 0.2215 |
Nov 17, 2023 | 0.2318 | 0.0085 | 3.81% | 0.2233 | 0.2369 | 0.2168 |
Nov 16, 2023 | 0.2170 | -0.0022 | -1.00% | 0.2192 | 0.2214 | 0.2124 |
Nov 15, 2023 | 0.2171 | -0.0079 | -3.51% | 0.2250 | 0.2250 | 0.2090 |
Nov 14, 2023 | 0.2297 | 0.0022 | 0.97% | 0.2275 | 0.2411 | 0.2092 |
Nov 13, 2023 | 0.2067 | 0.0006 | 0.29% | 0.2061 | 0.2144 | 0.2044 |
Nov 10, 2023 | 0.2092 | -0.0092 | -4.21% | 0.2184 | 0.2236 | 0.2068 |
Nov 9, 2023 | 0.2174 | -0.0109 | -4.77% | 0.2283 | 0.2332 | 0.2128 |
Nov 8, 2023 | 0.2294 | 0.0010 | 0.44% | 0.2284 | 0.2333 | 0.2256 |
Nov 7, 2023 | 0.2292 | -0.0091 | -3.82% | 0.2383 | 0.2383 | 0.2283 |
Nov 6, 2023 | 0.2312 | 0.0029 | 1.27% | 0.2283 | 0.2408 | 0.2262 |
Nov 3, 2023 | 0.2194 | 0.0035 | 1.62% | 0.2159 | 0.2299 | 0.2090 |
Nov 2, 2023 | 0.2106 | 0.0011 | 0.53% | 0.2095 | 0.2193 | 0.2042 |
Nov 1, 2023 | 0.2100 | -0.0149 | -6.63% | 0.2249 | 0.2258 | 0.2024 |
Oct 31, 2023 | 0.2219 | 0.0185 | 9.10% | 0.2034 | 0.2321 | 0.1993 |
Oct 30, 2023 | 0.2020 | -0.0099 | -4.67% | 0.2119 | 0.2153 | 0.2010 |
Asensus Surgical, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
Thursday, February 29, 2024 | ||
Time (UTC) 21:00 | Country US
| Event Q4 2023 Asensus Surgical Inc Earnings Release Q4 2023 Asensus Surgical Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 7.087 | 8.232 | 3.175 | 8.531 | 24.102 |
Revenue | 7.087 | 8.232 | 3.175 | 8.531 | 24.102 |
Cost of Revenue, Total | 10.872 | 11.096 | 5.166 | 20.731 | 16.171 |
Gross Profit | -3.785 | -2.864 | -1.991 | -12.2 | 7.931 |
Total Operating Expense | 82.766 | 70.004 | 63.564 | 163.106 | 73.254 |
Selling/General/Admin. Expenses, Total | 34.928 | 32.718 | 27.201 | 46.772 | 39.59 |
Research & Development | 28.942 | 19.348 | 16.621 | 22.468 | 21.823 |
Depreciation / Amortization | 7.708 | 11.254 | 10.801 | 10.301 | 10.868 |
Unusual Expense (Income) | 1.431 | -2.847 | 0.851 | 72.387 | -14.187 |
Other Operating Expenses, Total | -1.115 | -1.565 | 2.924 | -9.553 | -1.011 |
Operating Income | -75.679 | -61.772 | -60.389 | -154.575 | -49.152 |
Interest Income (Expense), Net Non-Operating | 0.731 | -1.761 | -0.32 | -1.783 | -17.128 |
Other, Net | -0.295 | 1.296 | -0.119 | -0.967 | 1.126 |
Net Income Before Taxes | -75.243 | -62.237 | -60.828 | -157.325 | -65.154 |
Net Income After Taxes | -75.561 | -62.462 | -59.312 | -154.201 | -61.777 |
Net Income Before Extra. Items | -75.561 | -62.462 | -59.312 | -154.201 | -61.777 |
Net Income | -75.561 | -62.462 | -59.312 | -154.201 | -61.777 |
Income Available to Common Excl. Extra. Items | -75.561 | -62.462 | -60.023 | -154.201 | -61.777 |
Income Available to Common Incl. Extra. Items | -75.561 | -62.462 | -60.023 | -154.201 | -61.777 |
Diluted Net Income | -75.561 | -62.462 | -60.023 | -154.201 | -61.777 |
Diluted Weighted Average Shares | 236.492 | 226.96 | 70.809 | 17.737 | 15.9384 |
Diluted EPS Excluding Extraordinary Items | -0.31951 | -0.27521 | -0.84767 | -8.69375 | -3.87599 |
Diluted Normalized EPS | -0.31557 | -0.28337 | -0.83986 | -5.88489 | -4.45456 |
Total Extraordinary Items | |||||
Total Adjustments to Net Income | 0 | -0.711 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 1.081 | 0.976 | 2.464 | 2.563 | 0.994 |
Revenue | 1.081 | 0.976 | 2.464 | 2.563 | 0.994 |
Cost of Revenue, Total | 3.074 | 2.947 | 2.298 | 4.404 | 2.347 |
Gross Profit | -1.993 | -1.971 | 0.166 | -1.841 | -1.353 |
Total Operating Expense | 21.944 | 23.324 | 20.591 | 21.595 | 20.561 |
Selling/General/Admin. Expenses, Total | 9.573 | 10.021 | 8.614 | 8.468 | 8.594 |
Research & Development | 8.98 | 10.139 | 8.52 | 6.741 | 7.253 |
Depreciation / Amortization | 0.114 | 0.112 | 0.107 | 2.398 | 2.533 |
Unusual Expense (Income) | 0 | 0.999 | 0 | 0.432 | |
Other Operating Expenses, Total | 0.203 | 0.105 | 0.053 | -0.416 | -0.598 |
Operating Income | -20.863 | -22.348 | -18.127 | -19.032 | -19.567 |
Interest Income (Expense), Net Non-Operating | 0.431 | 0.439 | 0.365 | 0.192 | 0.119 |
Other, Net | -0.242 | -0.218 | -0.034 | -0.029 | -0.086 |
Net Income Before Taxes | -20.674 | -22.127 | -17.796 | -18.869 | -19.534 |
Net Income After Taxes | -20.662 | -22.218 | -17.89 | -18.924 | -19.619 |
Net Income Before Extra. Items | -20.662 | -22.218 | -17.89 | -18.924 | -19.619 |
Net Income | -20.662 | -22.218 | -17.89 | -18.924 | -19.619 |
Total Adjustments to Net Income | |||||
Income Available to Common Excl. Extra. Items | -20.662 | -22.218 | -17.89 | -18.924 | -19.619 |
Income Available to Common Incl. Extra. Items | -20.662 | -22.218 | -17.89 | -18.924 | -19.619 |
Diluted Net Income | -20.662 | -22.218 | -17.89 | -18.924 | -19.619 |
Diluted Weighted Average Shares | 239.57 | 238.28 | 236.849 | 236.713 | 236.505 |
Diluted EPS Excluding Extraordinary Items | -0.08625 | -0.09324 | -0.07553 | -0.07994 | -0.08295 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.08625 | -0.09324 | -0.07279 | -0.07994 | -0.08177 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 86.873 | 113.297 | 34.013 | 27.955 | 101.583 |
Cash and Short Term Investments | 70.524 | 98.391 | 16.363 | 9.598 | 72.851 |
Cash & Equivalents | 6.329 | 18.129 | 16.363 | 9.598 | 21.061 |
Total Receivables, Net | 2.81 | 2.06 | 3.985 | 3.336 | 8.595 |
Accounts Receivable - Trade, Net | 2.256 | 0.749 | 1.115 | 0.62 | 8.56 |
Total Inventory | 8.284 | 8.634 | 10.034 | 10.653 | 10.941 |
Prepaid Expenses | 3.584 | 3.255 | 3.631 | 4.368 | 9.196 |
Total Assets | 116.053 | 186.473 | 78.258 | 74.779 | 239.307 |
Property/Plant/Equipment, Total - Net | 14.492 | 16.319 | 11.542 | 7.006 | 6.337 |
Property/Plant/Equipment, Total - Gross | 27.172 | 26.008 | 25.802 | 17.974 | 17.499 |
Accumulated Depreciation, Total | -12.68 | -9.689 | -14.26 | -10.968 | -11.162 |
Goodwill, Net | 0 | 80.131 | |||
Intangibles, Net | 1.576 | 9.892 | 22.267 | 31.066 | 50.463 |
Note Receivable - Long Term | |||||
Other Long Term Assets, Total | 9.247 | 9.53 | 10.436 | 8.752 | 0.793 |
Total Current Liabilities | 10.414 | 9.85 | 10.283 | 13.023 | 21.819 |
Accounts Payable | 3.348 | 3.448 | 1.965 | 3.579 | 4.433 |
Accrued Expenses | 6.601 | 5.859 | 6.301 | 8.553 | 9.228 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 1.228 | 0 | ||
Other Current Liabilities, Total | 0.465 | 0.543 | 0.789 | 0.891 | 8.158 |
Total Liabilities | 16.408 | 17.227 | 16.689 | 19.244 | 70.786 |
Total Long Term Debt | 0 | 0 | 1.587 | 0 | 28.937 |
Long Term Debt | 0 | 1.587 | 0 | 28.937 | |
Deferred Income Tax | 0 | 1.392 | 4.72 | ||
Other Liabilities, Total | 5.994 | 7.377 | 4.819 | 4.829 | 15.31 |
Total Equity | 99.645 | 169.246 | 61.569 | 55.535 | 168.521 |
Common Stock | 0.237 | 0.235 | 0.116 | 0.021 | 0.216 |
Additional Paid-In Capital | 962.731 | 954.649 | 781.397 | 720.484 | 676.373 |
Retained Earnings (Accumulated Deficit) | -860.935 | -785.374 | -722.912 | -663.6 | -509.406 |
Treasury Stock - Common | |||||
Other Equity, Total | -2.388 | -0.264 | 2.968 | -1.37 | 1.338 |
Total Liabilities & Shareholders’ Equity | 116.053 | 186.473 | 78.258 | 74.779 | 239.307 |
Total Common Shares Outstanding | 236.895 | 235.219 | 116.231 | 20.6913 | 16.6413 |
Short Term Investments | 64.195 | 80.262 | 0 | 51.79 | |
Redeemable Preferred Stock | 0 | 0 | 0 | ||
Total Preferred Shares Outstanding | 0 | ||||
Other Current Assets, Total | 1.671 | 0.957 | |||
Long Term Investments | 3.865 | 37.435 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total Current Assets | 45.932 | 54.91 | 71.556 | 86.873 | 103.53 |
Cash and Short Term Investments | 33.089 | 39.972 | 56.434 | 70.524 | 86.351 |
Cash & Equivalents | 21.669 | 7.675 | 18.737 | 6.329 | 13.87 |
Total Receivables, Net | 0.662 | 1.214 | 1.212 | 2.81 | 3.397 |
Accounts Receivable - Trade, Net | 0.662 | 0.66 | 0.658 | 2.256 | 2.25 |
Total Inventory | 6.683 | 9.083 | 8.844 | 8.284 | 9.035 |
Other Current Assets, Total | 1.324 | 1.492 | 1.74 | 1.671 | 1.034 |
Total Assets | 70.727 | 78.371 | 96.523 | 116.053 | 128.653 |
Property/Plant/Equipment, Total - Net | 14.241 | 13.703 | 13.741 | 14.492 | 13.944 |
Intangibles, Net | 1.278 | 1.411 | 1.506 | 1.576 | 1.529 |
Other Long Term Assets, Total | 9.276 | 8.347 | 8.762 | 9.247 | 7.713 |
Total Current Liabilities | 12.123 | 10.647 | 10.877 | 10.414 | 9.844 |
Accounts Payable | 4.526 | 4.281 | 4.972 | 3.348 | 3.637 |
Accrued Expenses | 7.141 | 5.99 | 5.449 | 6.601 | 5.85 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | |||||
Other Current Liabilities, Total | 0.456 | 0.376 | 0.456 | 0.465 | 0.357 |
Total Liabilities | 23.474 | 16.868 | 16.806 | 16.408 | 15.677 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Long Term Debt | |||||
Other Liabilities, Total | 11.351 | 6.221 | 5.929 | 5.994 | 5.833 |
Total Equity | 47.253 | 61.503 | 79.717 | 99.645 | 112.976 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | |
Common Stock | 0.264 | 0.24 | 0.239 | 0.237 | 0.237 |
Additional Paid-In Capital | 970.952 | 966.335 | 964.162 | 962.731 | 960.676 |
Retained Earnings (Accumulated Deficit) | -922.133 | -903.815 | -883.153 | -860.935 | -843.045 |
Other Equity, Total | -1.83 | -1.257 | -1.531 | -2.388 | -4.892 |
Total Liabilities & Shareholders’ Equity | 70.727 | 78.371 | 96.523 | 116.053 | 128.653 |
Total Common Shares Outstanding | 264.111 | 239.97 | 239.342 | 236.895 | 236.783 |
Total Preferred Shares Outstanding | |||||
Short Term Investments | 11.42 | 32.297 | 37.697 | 64.195 | 72.481 |
Prepaid Expenses | 4.174 | 3.149 | 3.326 | 3.584 | 3.713 |
Long Term Investments | 0 | 0 | 0.958 | 3.865 | 1.937 |
Property/Plant/Equipment, Total - Gross | 27.172 | ||||
Accumulated Depreciation, Total | -12.68 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -75.561 | -62.462 | -59.312 | -154.201 | -61.777 |
Cash From Operating Activities | -58.937 | -40.659 | -46.675 | -73.484 | -48.493 |
Cash From Operating Activities | 3.368 | 2.857 | 2.898 | 2.166 | 2.42 |
Amortization | 7.708 | 11.254 | 10.801 | 10.301 | 10.868 |
Deferred Taxes | 0.318 | 0.225 | -1.516 | -3.224 | -3.377 |
Non-Cash Items | 10.185 | 6.24 | 11.171 | 76.825 | 9.288 |
Cash Interest Paid | 0 | 0 | 2.187 | 1.73 | |
Changes in Working Capital | -4.955 | 1.227 | -10.717 | -5.351 | -5.915 |
Cash From Investing Activities | 47.537 | -119.668 | -0.003 | 67.645 | -53.481 |
Capital Expenditures | -1.279 | -1.368 | -0.003 | -0.437 | -0.77 |
Cash From Financing Activities | -0.332 | 161.705 | 53.37 | -5.609 | 26.452 |
Financing Cash Flow Items | -0.35 | -1.063 | -0.11 | -0.499 | -2.432 |
Issuance (Retirement) of Stock, Net | 0.018 | 162.768 | 50.665 | 26.315 | 15.682 |
Issuance (Retirement) of Debt, Net | 0 | 2.815 | -31.425 | 13.202 | |
Foreign Exchange Effects | -0.081 | 0.376 | 0.27 | 0.364 | -0.433 |
Net Change in Cash | -11.813 | 1.754 | 6.962 | -11.084 | -75.955 |
Other Investing Cash Flow Items, Total | 48.816 | -118.3 | 0 | 68.082 | -52.711 |
Cash Taxes Paid | -0.165 | -0.17 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -22.218 | -75.561 | -57.671 | -38.747 | -19.128 |
Cash From Operating Activities | -17.248 | -58.937 | -44.884 | -30.23 | -15.943 |
Cash From Operating Activities | 0.813 | 3.368 | 2.481 | 1.72 | 0.869 |
Amortization | 0.112 | 7.708 | 7.601 | 5.203 | 2.67 |
Deferred Taxes | 0.091 | 0.318 | 0.224 | 0.169 | 0.084 |
Non-Cash Items | 1.558 | 10.185 | 6.837 | 3.991 | 2.303 |
Changes in Working Capital | 2.396 | -4.955 | -4.356 | -2.566 | -2.741 |
Cash From Investing Activities | 29.737 | 47.537 | 41.21 | 23.173 | 23.045 |
Capital Expenditures | -0.064 | -1.279 | -0.904 | -0.443 | -0.246 |
Cash From Financing Activities | -0.483 | -0.332 | -0.332 | -0.331 | -0.336 |
Financing Cash Flow Items | -0.488 | -0.35 | -0.35 | -0.349 | -0.348 |
Issuance (Retirement) of Stock, Net | 0.005 | 0.018 | 0.018 | 0.018 | 0.012 |
Foreign Exchange Effects | 0.403 | -0.081 | -0.3 | 0.239 | -0.045 |
Net Change in Cash | 12.409 | -11.813 | -4.306 | -7.149 | 6.721 |
Issuance (Retirement) of Debt, Net | |||||
Other Investing Cash Flow Items, Total | 29.801 | 48.816 | 42.114 | 23.616 | 23.291 |
Cash Interest Paid | |||||
Cash Taxes Paid | -0.19 | -0.165 | 0.079 | 0.065 | -0.029 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 4.3177 | 11393457 | -43403 | 2023-06-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.3983 | 3689677 | 44503 | 2023-06-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.7989 | 2108122 | -159259 | 2023-06-30 | LOW |
Masters Capital Management, L.L.C. | Hedge Fund | 0.7579 | 2000000 | 157000 | 2023-06-30 | MED |
Biffi (Andrea) | Individual Investor | 0.7484 | 1974823 | 1482008 | 2023-04-14 | HIGH |
Millennium Management LLC | Hedge Fund | 0.6521 | 1720676 | -203224 | 2023-06-30 | HIGH |
Fernando (Anthony C J) | Individual Investor | 0.5641 | 1488393 | 0 | 2023-04-14 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.3611 | 952929 | -4200 | 2023-06-30 | LOW |
GSA Capital Partners LLP | Hedge Fund | 0.3415 | 901208 | 151408 | 2023-06-30 | HIGH |
Milne David Bruce | Individual Investor | 0.2349 | 619884 | 0 | 2023-04-14 | LOW |
UBS Financial Services, Inc. | Investment Advisor | 0.2231 | 588733 | 51763 | 2023-06-30 | LOW |
SV Health Investors, LLC | Venture Capital | 0.1933 | 510142 | 0 | 2022-09-30 | LOW |
AlphaCentric Advisors LLC. | Investment Advisor | 0.1895 | 500000 | 0 | 2023-06-30 | HIGH |
Pacific View Asset Management, LLC | Investment Advisor/Hedge Fund | 0.1895 | 500000 | 0 | 2023-06-30 | MED |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.166 | 438092 | -1490 | 2023-06-30 | LOW |
DWS Investment Management Americas, Inc. | Investment Advisor/Hedge Fund | 0.1094 | 288600 | 0 | 2023-06-30 | LOW |
Rampertab (Shameze) | Individual Investor | 0.0939 | 247863 | 9691 | 2023-07-01 | LOW |
Pfenniger (Richard C Jr) | Individual Investor | 0.0718 | 189417 | 45000 | 2023-06-06 | LOW |
T. Rowe Price International Ltd | Investment Advisor/Hedge Fund | 0.0703 | 185500 | 0 | 2023-06-30 | LOW |
T. Rowe Price Associates, Inc. | Investment Advisor | 0.0703 | 185500 | 0 | 2023-09-30 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Asensus Surgical, Inc. Company profile
Asensus Surgical (ASXC) is a medical device company that engages in digitising the interface between the surgeon and the patient to improve minimally invasive surgery (MIS).
Founded in 2006, Asensus is headquartered in Durham, North Carolina. It pioneers a new era of performance-guided surgery, using advanced capabilities, like machine vision, augmented intelligence, connectivity and robotics in laparoscopy.
Asensus has built the foundation of Digital Laparoscopy with the help of its Senhance Surgical System powered by the Intelligent Surgical Unit (ISU) to address clinical, cognitive and economic shortcomings in surgery.
The Senhance Surgical System is a multi-port robotic system that provides enhanced control with surgeon eye-tracking camera control & 3D (three dimensional) HD (high definition) vision and enhances precision through tremor filtrations and robotic stabilisation. Additionally, surgeons can have enhanced focus during surgery through Asensus’s optimised ergonomics and the sense of touch (haptics).
The surgical device that consists of a robotic instrument and a camera for laparoscopic procedures is considered to be the smallest instrument offered in robotics, leading to smaller incisions than traditional robotic surgery. Asensus’ Senhance ultrasonic system is an advanced energy device to deliver controlled energy to ligate and divide tissue.
Asensus Surgical previously developed the SPIDER device and the SurgiBot System. It changed its name from TransEnterix in February 2021. The company went public as TransEnterix in May 2014. It trades on the NYSE American under the ticker ‘ASXC’.
Industry: | Medical Equipment, Supplies & Distribution (NEC) |
1 Tw Alexander Drive
Suite 160
DURHAM
NORTH CAROLINA 27703
US
Income Statement
- Annual
- Quarterly
News

A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023
UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?
UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.
10:48, 21 November 2023
Gold Rises as Traders price-in Fed Rate Cuts
Gold prices have declined despite a drop in Treasury yields and a weaker US Dollar. We look at the key drivers and technical levels for the gold price.
13:17, 20 November 2023
XAU/USD Latest: Gold advances as weaker data weighs on US yields
Gold moves higher as softer economic data weighs on US yields and the dollar
13:43, 17 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com